MHRA: Multiple Field Safety Notices Issued August 2026 UK

• Between August 10th and 14th, 2026, the MHRA published several Field Safety Notices (FSNs) for various medical devices and pharmaceutical products.
• The FSNs include warnings related to an assistive scooter's electric motor, an interventional fluoroscopic X-ray system, and ultrasound systems.
• Compliance officers should review the list of published FSNs since January 2020 to ensure their clients are aware of any relevant notices.

The MHRA publishes these FSNs for information only, but it is crucial that recipients take action on them.

Between August 10th and 14th, 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) published several Field Safety Notices (FSNs). These notices are issued by manufacturers to alert users about potential safety issues with their products. The MHRA publishes these FSNs for information only, but it is crucial that recipients take action on them.

The list of FSNs includes notices for various medical devices and pharmaceutical products. For instance, there were warnings related to an assistive scooter's electric motor, an interventional fluoroscopic X-ray system, and ultrasound systems. Additionally, several non-organic haemostatic agents and information system software applications were also subject to FSNs.

It is essential for compliance officers and manufacturers to review the list of published FSNs since January 2020 to ensure that their clients are aware of any relevant notices.

Field Safety Notices (FSNs) from manufacturers must be acted upon by recipients. The MHRA's role is to publish these notices for information only, and it is up to the users to take necessary actions. This means that compliance officers should review the list of FSNs published since January 2020 to ensure their clients are aware of any relevant notices.

The MHRA reference numbers provided in each notice can be used to identify the specific product or issue addressed by the FSN. It is crucial for manufacturers and users to understand the importance of acting on these notices, as they may impact patient safety and device performance.

The publication of Field Safety Notices (FSNs) highlights the ongoing efforts of manufacturers to ensure the safety and efficacy of their products. The MHRA's role in publishing these notices for information only underscores the importance of compliance with regulatory requirements.

For lawyers, it is essential to note that FSNs from manufacturers must be acted upon, and the MHRA publishes them for information only. Compliance officers should review the list of FSNs published since January 2020 to ensure their clients are aware of any relevant notices.

Lawyers should note that Field Safety Notices (FSNs) from manufacturers must be acted upon, and the MHRA publishes these for information only. Compliance officers should review the list of FSNs published since January 2020 to ensure their clients are aware of any relevant notices.

Source: Original reporting via GOV.UK